Based on limited published evidence, MS4A15 is a transmembrane protein predicted to function in signal transduction as a component of multimeric receptor complexes at the plasma membrane. In ovarian cancer, MS4A15 acts as an oncogene, promoting tumor growth through reprogramming of energy metabolism, enhancing lipid synthesis and oxidative phosphorylation 1. Conversely, in lung adenocarcinoma, MS4A15 expression is reduced in tumors and positively correlates with immune cell infiltration, particularly mast cells, suggesting a tumor-suppressive role 2. These opposing functions across cancer types indicate MS4A15 has context-dependent roles in cancer progression.